Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solid tumours--chemoprevention with retinoids

T Man1

  • 1Roche International Clinical Research Centre, Lingolsheim, France.

Leukemia
|October 1, 1994
PubMed
Summary

Retinoids show promise in preventing early-stage cancers and second primary tumors. Further research is needed to overcome challenges in clinical development for these chemoprevention agents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for new-onset diabetes mellitus following acute pancreatitis: a prospective study.

European review for medical and pharmacological sciences·2022
Same author

Leptin involvement in the survival of pancreatic adenocarcinoma patients with obesity and diabetes.

European review for medical and pharmacological sciences·2022
Same author

The mechanics of mitotic chromosomes.

Quarterly reviews of biophysics·2021
Same author

Solid tumours--chemoprevention with retinoids.

Leukemia·1994
Same author

EVA treatment for recurrent or unresponsive Hodgkin's disease.

Cancer chemotherapy and pharmacology·1986
Same author

[Incidence of B. cereus in raw milk and pasteurized milk].

Microbiologia, parazitologia, epidemiologia·1966

Area of Science:

  • Oncology
  • Chemoprevention

Background:

  • Cancer treatment is shifting towards early-stage disease.
  • Retinoids are a promising class of drugs for cancer chemoprevention.
  • Different retinoids exhibit varying antitumoral activities and can synergize with cytokines.

Purpose of the Study:

  • To explore the potential of retinoids in cancer chemoprevention.
  • To investigate the role of retinoid receptors in designing more effective compounds.
  • To address challenges in the clinical development of retinoid-based chemoprevention strategies.

Main Methods:

  • Review of preclinical data and clinical experience with retinoids.
  • Evaluation of existing and ongoing clinical studies for retinoid efficacy.
  • Discussion of challenges in study design, patient selection, and trial endpoints.

Main Results:

  • 13-cis retinoic acid shows activity in preventing head and neck second primary tumors.
  • Fenretidinide is under investigation for breast cancer second primary tumor prevention.
  • Understanding retinoid receptor function could lead to improved therapeutic indices.

Conclusions:

  • Retinoids hold potential for cancer chemoprevention, particularly for early-stage disease and second primary tumors.
  • Significant challenges remain in clinical development, including study design and patient selection.
  • Further clinical studies, especially in tobacco-related cancers, are crucial to define the role of retinoids.

Related Experiment Videos